Infusion Pump Market Report 2025

The infusion pump market size has grown strongly in recent years. It will grow from $14.77 billion in 2024 to $15.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to aging population, chronic diseases, hospitalization trends, surgical procedures, advancements in healthcare.

The infusion pump market size is expected to see strong growth in the next few years. It will grow to $22.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to home healthcare trends, rise in ambulatory care centers, global health challenges, technological integration, patient empowerment. Major trends in the forecast period include development of wearable infusion devices, expansion of ambulatory infusion centers, customization for pediatric and geriatric patients, focus on cost-effectiveness and efficiency, integration of artificial intelligence in infusion systems.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the infusion pump market in the coming years. Chronic diseases, also known as noncommunicable diseases (NCDs), are long-term health conditions that typically develop gradually over an extended period. The rising incidence of chronic conditions, such as cancer and diabetes, is largely attributed to lifestyle changes, sedentary behaviors, declining quality of life, and unhealthy eating habits. Infusion pumps are utilized to manage some of these chronic diseases by providing accurate dosing, precise fluid delivery, and tailored treatments. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that the number of individuals with chronic diseases globally would reach 142.66 million by 2050, an increase from 71.522 million in 2020. Additionally, the International Diabetes Federation, which represents over 230 national diabetes associations in more than 160 countries and territories, estimated that there would be 643 million diabetics worldwide by 2030, rising to 783 million by 2045. Consequently, the increasing prevalence of chronic diseases is expected to boost the growth of the infusion pump market.

The growth of the infusion pump market is further propelled by the increase in surgical procedures. Infusion pumps play a critical role in surgical settings, ensuring the precise and controlled delivery of medications, including anesthesia, pain management drugs, and specialized therapies. They contribute to intravenous fluid management, postoperative pain control, and the administration of parenteral nutrition. The rise in ambulatory and minimally invasive surgeries has heightened the demand for portable and ambulatory infusion pumps. For instance, in 2022, there was an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures compared to 131,612 in 2021. Therefore, the surge in surgical procedures is a driving force for the growth of the infusion pump market.

Technological advancement has become a significant trend gaining traction in the infusion pump market. Leading companies in this sector are focused on creating new technological solutions to enhance their market positions. For example, in November 2022, Medtronic, a US-based medical device company, launched the MiniMed Quick-set Plus, the world's first and only insulin pump infusion set. This innovative product was developed using advanced components that help reduce insulin preservative loss while maintaining insulin flow and stability, effectively doubling the wear time of an infusion set. It is the first infusion set to receive FDA approval and aims to provide a more convenient and comfortable experience for diabetes patients.

Key players in the infusion pump market are also focusing on the development of infusion management software to gain a competitive advantage. Infusion management software comprises specialized computer programs designed to oversee and optimize the administration of fluids, medications, and other therapeutic agents via infusion pumps in healthcare settings. For instance, in June 2023, B. Braun Medical Inc., a US-based medical device manufacturing company, introduced the DoseTrac Enterprise Infusion Management Software. This advanced software offers healthcare organizations real-time views and retrospective reporting features, enabling them to manage their infusion pump fleets and related data effectively. The platform can connect up to 40,000 pumps across multiple facilities through a single application, facilitating centralized management regardless of fleet size or the number of locations. DoseTrac Enterprise aims to enhance data management and may reduce the clinical IT infrastructure needed for infusion pumps.

In March 2022, Fresenius Kabi, a Germany-based company specializing in lifesaving medicines and technology, acquired Ivenix Inc. for an undisclosed sum. This acquisition is set to create a comprehensive portfolio for Fresenius Kabi, featuring the most advanced infusion pump technology, along with infusion supplies and accessories. Ivenix Inc. is a US-based manufacturer of intravenous drug infusion pump systems.

Major companies operating in the infusion pump market include Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Smiths Medical Inc., Medtronic plc, Moog Inc., Terumo Corporation, Insulet Corporation, Boston Scientific Corporation, Tandem Diabetes Care Inc., InfuTronix Solutions LLC, Micrel Medical Devices SA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Mindray Medical International Limited, Caesarea Medical Electronics Ltd., Hospitech Respiration Ltd., IRadimed Corporation, Ivenix Inc., Sooil Development Co. Ltd., ZOLL Medical Corporation, Zyno Medical LLC.

North America was the largest region in the infusion pump market in 2024. The regions covered in the infusion pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infusion pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An infusion pump is a medical device utilized to deliver fluids, including medications or nutrients, into a patient's bloodstream in a controlled manner. The functioning of infusion pumps relies on a pump mechanism to regulate the rate and volume of fluid administered to the patient.

The primary product types of infusion pumps include accessories and consumables, along with devices. Accessories and consumables encompass additional components designed to enhance the performance or functionality of the medical device. Various pump types are available, such as volumetric infusion pumps, insulin pumps, enteral infusion pumps, syringe infusion pumps, ambulatory infusion pumps, PCA pumps, and implantable infusion pumps. These pumps utilize technologies ranging from traditional infusion pumps to specialty infusion pumps. Applications for infusion pumps cover areas such as chemotherapy or oncology, diabetes management, gastroenterology, pain management or analgesia, pediatrics or neonatology, hematology, and others. They are used across diverse settings, including hospitals, ambulatory care settings, specialty clinics, and home care settings.

The infusion pump market research report is one of a series of new reports that provides infusion pump market statistics, including infusion pump industry global market size, regional shares, competitors with a infusion pump market share, detailed infusion pump market segments, market trends and opportunities, and any further data you may need to thrive in the infusion pump industry. This infusion pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infusion pump market consists of sales of large volume infusion pump and elastomeric infusion pump. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.